Follow
Kevin Gardinier
Kevin Gardinier
Novartis Institutes of Biomedical Research
Verified email at novartis.com
Title
Cited by
Cited by
Year
Enforced Helicity: Efficient Access to Self‐Organized Helical Molecular Strands by the Imine Route
KM Gardinier, RG Khoury, JM Lehn
Chemistry–A European Journal 6 (22), 4124-4131, 2000
1002000
New chemical modalities and strategic thinking in early drug discovery
MJ Blanco, KM Gardinier
ACS medicinal chemistry letters 11 (3), 228-231, 2020
842020
Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism
AS Kato, KD Burris, KM Gardinier, DL Gernert, WJ Porter, J Reel, C Ding, ...
Nature medicine 22 (12), 1496-1501, 2016
822016
Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic …
R Zwart, E Sher, X Ping, X Jin, JR Sims, AS Chappell, SD Gleason, ...
Journal of Pharmacology and Experimental Therapeutics 351 (1), 124-133, 2014
772014
Enantiospecific total synthesis of the potent antitumor macrolides cryptophycins 1 and 8
KM Gardinier, JW Leahy
The Journal of Organic Chemistry 62 (21), 7098-7099, 1997
741997
Janus molecules: Synthesis of double-headed heterocycles containing two identical hydrogen bonding arrays
A Marsh, EG Nolen, KM Gardinier, JM Lehn
Tetrahedron letters 35 (3), 397-400, 1994
611994
Discovery of the first α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist dependent upon transmembrane AMPA receptor regulatory protein (TARP) γ-8
KM Gardinier, DL Gernert, WJ Porter, JK Reel, PL Ornstein, P Spinazze, ...
Journal of medicinal chemistry 59 (10), 4753-4768, 2016
562016
Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1 …
J Hao, JP Beck, JM Schaus, JH Krushinski, Q Chen, CD Beadle, P Vidal, ...
Journal of Medicinal Chemistry 62 (19), 8711-8732, 2019
492019
Radiolabeling of a high potency cannabinoid subtype‐1 receptor ligand, N‐(4‐fluoro‐benzyl)‐4‐(3‐(piperidin‐1‐yl)‐indole‐1‐sulfonyl)benzamide (PipISB), with …
SR Donohue, C Halldin, M Schou, J Hong, L Phebus, E Chernet, ...
Journal of Labelled Compounds and Radiopharmaceuticals: The Official Journal …, 2008
332008
Untitled
WO Patent 2003091226:A1, 0
31*
MCH receptor antagonists
MB Arnold, Y Dao, KM Gardinier, DJ Garmene, SJ Green, EJ Hembre, ...
US Patent 8,263,772, 2012
272012
Structural determinants of the γ-8 TARP dependent AMPA receptor antagonist
MR Lee, KM Gardinier, DL Gernert, DA Schober, RA Wright, H Wang, ...
ACS chemical neuroscience 8 (12), 2631-2647, 2017
232017
Tachykinin receptor antagonists
AK Amegadzie, KM Gardinier, EJ Hembre, JE Hong, LN Jungheim, ...
US Patent 7,179,804, 2007
222007
Reconstitution of synaptic Ion channels from rodent and human brain in Xenopus oocytes: a biochemical and electrophysiological characterization
F Mazzo, R Zwart, GM Serratto, KM Gardinier, W Porter, J Reel, G Maraula, ...
Journal of neurochemistry 138 (3), 384-396, 2016
212016
Modulation of TARP γ8–Containing AMPA Receptors as a Novel Therapeutic Approach for Chronic Pain
KL Knopp, RMA Simmons, W Guo, BL Adams, KM Gardinier, DL Gernert, ...
Journal of Pharmacology and Experimental Therapeutics 369 (3), 345-363, 2019
172019
Advancing new chemical modalities into clinical studies
MJ Blanco, KM Gardinier, MN Namchuk
ACS Medicinal Chemistry Letters 13 (11), 1691-1698, 2022
162022
Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptors
JM Witkin, J Li, G Gilmour, SN Mitchell, G Carter, SD Gleason, WF Seidel, ...
Neuropharmacology 126, 257-270, 2017
152017
Retinoid X receptor modulators
KM Gardinier, DL Gernert, TA Grese, DA Neel, CM Mapes, PY Michellys, ...
US Patent 7,348,359, 2008
122008
Triazole derivatives as tachykinin receptor antagonists
AK Amegadzie, KM Gardinier, EJ Hembre, JE Hong, LN Jungheim, ...
US Patent 7,320,994, 2008
122008
Targeted blockade of TARP-γ8-associated AMPA receptors: anticonvulsant activity with the selective antagonist LY3130481 (CERC-611)
JM Witkin, DA Schober, SD Gleason, JT Catlow, WJ Porter, J Reel, X Jin, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017
112017
The system can't perform the operation now. Try again later.
Articles 1–20